Thyrotoxicosis syndrome: new clinical opportunities for the correction of thyroid dysfunction

Main Article Content

V.I. Pankiv

Abstract

The article deals with the analysis of the literature on the study of the spectrum of therapeutic properties of Potentilla alba preparation, supplemented with selenium and zinc, which is prescribed in addition to standard management of patients with thyroid hyperfunction. Drug is used alone in subclinical thyrotoxicosis degree I, as well as in achieving stable compensation of diffuse toxic goiter; and as a part of comprehensive therapy — in subclinical thyrotoxicosis degree II, diffuse toxic goiter for normalization of T4 and T3 content in the blood.

Article Details

How to Cite
Pankiv, V. “Thyrotoxicosis Syndrome: New Clinical Opportunities for the Correction of Thyroid Dysfunction”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 16, no. 1, Feb. 2020, pp. 58-62, doi:10.22141/2224-0721.16.1.2020.199129.
Section
Literature Review

References

Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. doi:10.1089/thy.2016.0229.

Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–931. doi:10.1210/jc.2013-2409.

Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. doi:10.1210/jcem.87.2.8182.

Vejbjerg P, Knudsen N, Perrild H, et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf). 2009;71(3):440–445. doi:10.1111/j.1365-2265.2008.03493.x.

Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J. 2015;4(3):149–163. doi:10.1159/000438750.

Lee BC, Kang SI, Ahn YM, Doo HK, Ahn SY. An alternative therapy for graves' disease: clinical effects and mechanisms of an herbal remedy. Biol Pharm Bull. 2008;31(4):583–587. doi:10.1248/bpb.31.583.

Bacyuk Ponych NV. Cinquefoil (Potentilla) Remedies in clinical practice: folk and contemporary pharmaceutical forms of administration (literary review). Fitoterapia. 2013;(4):29–33. (in Ukrainian).

Gritsenko OM, Smyk GK. The phytochemical study of Potentilla alba. Farm Zh. 1977;32(1):88–92. (in Ukrainian).

Zaharija AV. Doslidzhennja perstachu bilogo jak perspektyvnogo zasobu dlja likuvannja zahvorjuvan' shhytovydnoi' zalozy: eksperymental'ne doslidzhennja. Diss. kand. biol. nauk [Investigation of white cinquefoil as a promising agent for the treatment of thyroid gland diseases: experimental study. PhD in Biol Sci diss.]. Lviv; 1997. 202 p. (in Ukrainian).

Semenova EF, Presniakova EV. The chemical composition of Potentilla alba and its therapeutic use. In: Proceeding of the I Russian scientific-practical conference on Actual problems of innovation with non-traditional plant resources and the creation of functional products. 2001, June 18-19; Moscow, Russian Federation. Chemistry and Computational Simulation. Butlerov Communications. 2001;2(5)(Suppl):32–34. (in Russian).

Shikov AN, Lazukina MA, Pozharitskaya ON, et al. Pharmacological evaluation of Potentilla alba L. in mice: adaptogenic and central nervous system effects. Pharm Biol. 2011;49(10):1023–1028. doi:10.3109/13880209.2011.560162.

Kravchun NA, Kazakov AV, Cherniavskaia IV. Therapeutic correction of autoimmune thyroiditis with hypo- and hyperfunction of the thyroid gland. Problems of Endocrine Pathology. 2010;(3):36–40 (in Russian).

Kaminskiĭ AV, Kiseleva IA, Teplaia EV. Clinical Application of Potentilla Alba for Prevention and Treatment of Thyroid Gland Pathologies. Lik Sprava. 2013;(8):99–108. (in Russian).

Tomczyk M, Latté KP. Potentilla--a review of its phytochemical and pharmacological profile. J Ethnopharmacol. 2009;122(2):184–204. doi:10.1016/j.jep.2008.12.022.

Wiater A, Pleszczynska M, Próchniak K, Szczodrak J. Anticariogenic activity of the crude ethanolic extract of Potentilla erecta (L.) Raeusch. Herba Polonica. 2008;54(2):41–45.

Pashkovska NV. Selenium and autoimmune thyroid disorders. Mìžnarodnij endokrinologìčnij žurnal 2017;13(1):33–38. doi:10.2214/2224-0721.13.1.2017.96753. (in Ukrainian).

Troshina EA, Senyushkina ES, Terekhova MA. The role of selenium in the pathogenesis of thyroid disease. Klinicheskaia I eksperimentalnaia tiroidologia. 2018;14(4):192–205. doi:10.14341/ket10157 . (in Russian).

Honcharova OA, Illina IM. Selenium deficiency and age-related diseases (in the focus of deiodinase). Mìžnarodnij endokrinologìčnij žurnal. 2015;(68):87–92. doi:10.22141/2224-0721.4.68.2015.75020. (in Russian).

Kvacheniuk AN, Kvacheniuk EL. The use of phytotherapy for treatment of thyroid diseases. Lik Sprava. 2012;(3-4):99–104. (in Russian).

Severo JS, Morais JBS, de Freitas TEC, et al. The Role of Zinc in Thyroid Hormones Metabolism. Int J Vitam Nutr Res. 2019;89(1-2):80–88. doi:10.1024/0300-9831/a000262.

Jain RB. Thyroid function and serum copper, selenium, and zinc in general U.S. population. Biol Trace Elem Res. 2014;159(1-3):87–98. doi:10.1007/s12011-014-9992-9.

Mahmoodianfard S, Vafa M, Golgiri F, et al. Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial. J Am Coll Nutr. 2015;34(5):391–399. doi:10.1080/07315724.2014.926161.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 11 12 > >>